← Evidence map

ArticleClinical pharmacology : advances and applications2021

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study.

David Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34140814